Latest filing published 27 Jul 2021 for ASCENTAGE PHARMA GROUP INTERNATIONAL, €6,696.
Filing timeline
BuySaleInsider track record
Kmetz Raymond Jeffrey: trading record in brief
Kmetz Raymond Jeffrey is a declared insider of Ascentage Pharma Group International, with filings sourced from SEC (Form 4). In total, 9 filings cover trades dated from 4 December 2020 to 24 June 2021.
The open-market record consists of 5 sales worth €365k, with no purchase. So far in 2021, the count stands at no purchases and 4 sales.
Most recently, on 27 July 2021, the filings show an open-market sale worth €174k in Ascentage Pharma Group International. Filings reach the SEC (Form 4) feed a median of 35 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kmetz Raymond Jeffrey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,300 shares@ HK$47.701.8% of flowShareXHKGHKEX:DA20210727E00550
- 46,875 shares@ HK$0.010.0% of flowShareXHKGHKEX:DA20210727E00548
- 713 shares@ HK$44.730.9% of flowShareXHKGHKEX:DA20210727E00541
- 700 shares@ HK$0.010.0% of flowShareXHKGHKEX:DA20210727E00534
- 100 shares@ HK$42.750.1% of flowShareXHKGHKEX:DA20210727E00530
- 100 shares@ HK$0.010.0% of flowShareXHKGHKEX:DA20210727E00526
- 56,500 shares@ HK$29.0047.7% of flowShareXHKGHKEX:DA20210727E00518
- 56,567 shares@ HK$30.0049.4% of flowShareXHKGHKEX:DA20201211E00242
- 56,567 shares@ HK$0.010.0% of flowShareXHKGHKEX:DA20201209E00222
9 of 9 declarations